학술논문
Inhibitory activity of FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, remdesivir, and hydroxychloroquine on COVID-19 main protease and human ACE2 receptor: A comparative in silico approach
Document Type
Article
Source
In Informatics in Medicine Unlocked 2021 26
Subject
Language
ISSN
2352-9148